Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hemolytic uremic syndrome].

C Mele1, M Noris

  • 1Istituto di Ricerche Farmacologiche Mario Negri, Centro di Ricerche Cliniche per le Malattie Rare, Aldo e Cele Daccò, Villa Camozzi, Ranica - Italy. mele@marionegri.it

Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|March 8, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Screening performance of the FINDRISC score for identification of undiagnosed type 2 diabetes in persons with severe obesity.

Diabetology & metabolic syndrome·2026
Same author

Tumor enlargement in adrenal incidentaloma is related to glaucoma: a new prognostic feature?

Journal of endocrinological investigation·2023
Same author

Real-world evaluation of weekly subcutaneous treatment with semaglutide in a cohort of Italian diabetic patients.

Journal of endocrinological investigation·2022
Same author

Gestational Diabetes Mellitus: Clinical Characteristics and Perinatal Outcomes in a Multiethnic Population of North Italy.

International journal of endocrinology·2022
Same author

Thyroid function in the subacute phase of traumatic brain injury: a potential predictor of post-traumatic neurological and functional outcomes.

Journal of endocrinological investigation·2021
Same author

Angiopoietin-like 8 (ANGPTL8) as a potential predictor of NAFLD in paediatric patients with Prader-Willi Syndrome.

Journal of endocrinological investigation·2020
Same journal

[Rufus of Ephesus, On gout].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same journal

A Case Report and Literature Review: Chlorhexidine-induced anaphylaxis in a hemodialysis patient.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same journal

New Frontiers in the Treatment of Chronic Kidney Disease-associated Pruritus: A Case of Hemoperfusion with HA130.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same journal

Fibronectin Glomerulopathy: A Case Report of Membranoproliferative Glomerulonephritis.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same journal

Sodium Disorders in Multiple Myeloma: Beyond Pseudohyponatremia to Clinical Pitfalls and Mechanistic Insights.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same journal

Acute Kidney Injury and Early Diagnostic Biomarkers: A Narrative Literature Review.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
See all related articles

Genetic factors influence non-Shiga toxin-associated Hemolytic Uremic Syndrome (HUS). Understanding complement system gene mutations, like CFH, CFI, and MCP, guides tailored treatments and improves patient outcomes.

Area of Science:

  • Nephrology
  • Genetics
  • Immunology

Context:

  • Hemolytic Uremic Syndrome (HUS) is a severe condition involving microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury.
  • Non-Shiga toxin-associated HUS (non-Stx-HUS) encompasses diverse cases unrelated to Shiga-like toxin-producing bacteria.
  • The complement system's alternative pathway is implicated in non-Stx-HUS pathogenesis.

Purpose:

  • To elucidate the genetic underpinnings of non-Stx-HUS.
  • To identify specific complement regulatory protein gene mutations associated with non-Stx-HUS.
  • To correlate genetic findings with therapeutic responses and patient prognosis.

Summary:

  • Genetic studies reveal that non-Stx-HUS is often caused by deficiencies or abnormalities in complement regulatory proteins, including Factor H (CFH), Membrane Cofactor Protein (MCP), and Factor I (CFI).

Related Experiment Videos

  • Mutations in CFH and CFI genes, encoding plasma proteins, suggest that plasma-based therapies like infusion or exchange are beneficial.
  • Conversely, mutations in the MCP gene, a membrane-bound protein, indicate that plasma treatments are less effective, but kidney transplantation shows favorable outcomes.

    • Impact:

    • Genetic analysis provides crucial insights into the molecular mechanisms of non-Stx-HUS.
    • Distinguishing between genetic subtypes of non-Stx-HUS allows for personalized treatment strategies, optimizing therapeutic efficacy.
    • Understanding these genetic variations improves prognostic predictions, particularly regarding kidney transplantation outcomes and disease recurrence.